Full-Time

Scientist – LC-MS

Confirmed live in the last 24 hours

Orbital Therapeutics

Orbital Therapeutics

51-200 employees

Develops RNA-based medicines and vaccines

Data & Analytics

Mid

Cambridge, MA, USA

Requirements
  • Ph.D. in Analytical Chemistry, Biochemistry or related discipline with 1+ years of experience; B.S./M.S. with appropriate years of experience will be considered.
  • Strong experience analyzing biological samples using chromatography (HPLC/UPLC) in various modes (reversed phase, ion exchange, etc.) and associated detection methods is required, especially mass spectrometry (MS) and charged aerosol detection (CAD).
  • Experience with RNA, lipid nanoparticles, and/or proteomics is strongly preferred.
  • Familiarity with GxP principles for development, documentation, qualification is preferred.
  • Ability to work independently as well as in a team.
  • Detail-oriented in assay execution and documentation.
Responsibilities
  • Develop new analytical methods to characterize RNA-based products and their delivery systems utilizing expertise in chromatography (HPLC/UPLC).
  • Explore new techniques and technologies to provide analytical support of research and development at all stages.
  • Participate in method transfer to third parties as necessary, including providing expertise and documentation (SOPs, technical reports, method qualification plans) to assist in method verification, qualification, and validation.
  • Partner collaboratively with internal teams (process development, research, preclinical manufacturing) to meet analytical development and routine testing needs.
  • Lead, perform/guide troubleshooting when necessary.
  • Oversee routine analytical testing and review data as well as perform routine testing when necessary.
  • Operate and maintain HPLC and mass spectrometry instruments.
  • Purchase and maintain analytical reagents and standards.
  • Document and communicate results to team members and leaders.
  • Approach analytical challenges creatively and help build up a cutting edge analytical platform.

Orbital Therapeutics is a leader in RNA-based medicine development, integrating cutting-edge RNA technology, advanced delivery methods, and powerful data analytics. Their collaborative and innovative culture propels the creation of novel vaccines and treatments for immunomodulation, protein replacement, and regenerative medicine, offering a stimulating environment for professionals passionate about impacting human health on a global scale.

Company Stage

Series A

Total Funding

$320M

Headquarters

Cambridge, Massachusetts

Founded

2022

Growth & Insights
Headcount

6 month growth

20%

1 year growth

34%

2 year growth

268%